.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Citi
Baxter
UBS
US Department of Justice
Fish and Richardson
Teva
Mallinckrodt
Federal Trade Commission
Dow

Generated: February 18, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: exenatide synthetic

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Astrazeneca AbBYDUREONexenatide syntheticFOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS022200NDAAstraZeneca Pharmaceuticals LPN0310-6520-04
Astrazeneca AbBYDUREONexenatide syntheticFOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS022200NDAAstraZeneca Pharmaceuticals LPN0310-6530-85
Astrazeneca AbBYDUREONexenatide syntheticFOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS022200NDAAstraZeneca Pharmaceuticals LPN0310-6530-04
Astrazeneca AbBYDUREONexenatide syntheticFOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS022200NDAAstraZeneca Pharmaceuticals LPN0310-6530-01
Astrazeneca AbBYDUREON PENexenatide syntheticFOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS022200NDAAstraZeneca Pharmaceuticals LPN0310-6520-04
Astrazeneca AbBYDUREON PENexenatide syntheticFOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS022200NDAAstraZeneca Pharmaceuticals LPN0310-6530-85
Astrazeneca AbBYDUREON PENexenatide syntheticFOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS022200NDAAstraZeneca Pharmaceuticals LPN0310-6530-04
Astrazeneca AbBYDUREON PENexenatide syntheticFOR SUSPENSION, EXTENDED RELEASE;SUBCUTANEOUS022200NDAAstraZeneca Pharmaceuticals LPN0310-6530-01
Astrazeneca AbBYETTAexenatide syntheticINJECTABLE;SUBCUTANEOUS021773NDAAstraZeneca Pharmaceuticals LPN0310-6512-01
Astrazeneca AbBYETTAexenatide syntheticINJECTABLE;SUBCUTANEOUS021773NDAAstraZeneca Pharmaceuticals LPN0310-6524-01
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Johnson and Johnson
Cantor Fitzgerald
Fuji
Teva
Fish and Richardson
Accenture
Julphar
US Department of Justice
Farmers Insurance

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot